ALEC Since 2019 Annualized Return and Average Annual Return

ALEC Average Annual Return Chart Since 2019
Growth of $10,000.00
Without Dividends Reinvested Into ALEC

Also see:
• ALEC stock yearly return 2020
• ALEC stock yearly return 2021
• ALEC stock yearly return 2022
• ALEC stock yearly return 2023
• ALEC stock yearly return 2024
• ALEC stock yearly return 2025
• ALEC YTD return
Average Annual Return Benchmarks
Compare ALEC average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
ALEC Share Performance
ALEC Average Annual Return Table Since 2019
Start date: 02/08/2019
End date: 09/09/2026
Start price/share: $16.30
End price/share: $2.27
Dividends collected/share: $0.00
Total return: -86.07%
ALEC Average Annual Return: -22.88%
Starting investment: $10,000.00
Ending investment: $1,393.20
Years: 7.59


ALEC average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
About Alector Inc
Alector, Inc. is a clinical-stage biotechnology company. Co. is focused on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration diseases. Co. is engaged in developing therapies designed to counteract these pathologies simultaneously by restoring healthy immune function to the brain. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration and immunology to identify immune system. Its product candidates: latozinemab (AL001), AL002, and AL101, are in clinical development. The ALEC average annual return since 2019 is shown above.

The Average Annual Return on the ALEC average annual return since 2019 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether ALEC average annual return since 2019 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the ALEC average annual return calculation with any dividends reinvested as applicable (on ex-dates).
ALEC Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree ALEC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Featured Slideshows
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!
Video: Don't Forget Dividends in Average Annual Return!
Average Annual Return Peers
Alector (ALEC) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

ALGN Average Annual Return
ALGS Average Annual Return
ALHC Average Annual Return
ALKS Average Annual Return
ALLO Average Annual Return
ALLR Average Annual Return
ALMS Average Annual Return
ALNY Average Annual Return
ALT Average Annual Return
ALUR Average Annual Return
More Healthcare companies »
 

ALEC Average Annual Return Since 2019 | www.AverageAnnualReturn.com | Copyright © 2021 - 2026, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.